Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Liabilities and Shareholders Equity (2016 - 2025)

cbdMD's Liabilities and Shareholders Equity history spans 10 years, with the latest figure at $11.8 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 2.07% to $11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $43.0 million, a 14.81% decrease, with the full-year FY2025 number at $10.4 million, down 1.53% from a year prior.
  • Liabilities and Shareholders Equity hit $11.8 million in Q4 2025 for cbdMD, up from $10.4 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for YCBD hit a ceiling of $124.9 million in Q3 2021 and a floor of $9.9 million in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $43.9 million across 5 years, with a median of $24.6 million in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: increased 12.67% in 2021 and later crashed 67.34% in 2022.
  • Tracing YCBD's Liabilities and Shareholders Equity over 5 years: stood at $99.3 million in 2021, then tumbled by 64.03% to $35.7 million in 2022, then plummeted by 57.75% to $15.1 million in 2023, then dropped by 23.53% to $11.5 million in 2024, then increased by 2.07% to $11.8 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for YCBD at $11.8 million in Q4 2025, $10.4 million in Q3 2025, and $9.9 million in Q2 2025.